We are live on ! Find out more
CSTL icon

Castle Biosciences
CSTL

89 hedge funds and large institutions have $220M invested in Castle Biosciences in 2020 Q1 according to their latest regulatory filings, with 32 funds opening new positions, 37 increasing their positions, 14 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed

220% more first-time investments, than exits

New positions opened: 32 | Existing positions closed: 10

164% more repeat investments, than reductions

Existing positions increased: 37 | Existing positions reduced: 14

33% more funds holding

Funds holding: 67 → 89 (+22)

25% more capital invested

Capital invested by funds: $176M → $220M (+$44.5M)

13.02% more ownership

Funds ownership: 29.93% → 42.94% (+13%)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

Holders
89
Holders Change
+22
Holders Change %
+32.84%
% of All Funds
1.96%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
32
Increased
37
Reduced
14
Closed
10
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
+$8.45M
2
WA
Wasatch Advisors
Utah
+$8.26M
3
TFS
TrustCore Financial Services
Tennessee
+$7.81M
4
Wells Fargo
Wells Fargo
California
+$7.68M
5
Millennium Management
Millennium Management
New York
+$6.32M

Top Sellers

Rank Fund Capital Flow
1
PCM
Portolan Capital Management
Massachusetts
-$5.13M
2
EIM
Essex Investment Management
Massachusetts
-$1.86M
3
ZP
Zimmer Partners
New York
-$1.75M
4
N
Nuveen
North Carolina
-$1.52M
5
Lord, Abbett & Co
Lord, Abbett & Co
New Jersey
-$1.24M
Name Holding Trade Value Shares
Change 		Change in
Stake
N
26
Nuveen
North Carolina
$1.92M -$1.52M -50,272 -44%
CCM
27
Cadence Capital Management
Massachusetts
$1.84M +$1.86M +61,791 New
EGI
28
EAM Global Investors
California
$1.68M +$215K +7,119 +14%
CP
29
Covenant Partners
Tennessee
$1.65M +$1.67M +55,344 New
PI
30
Putnam Investments
Massachusetts
$1.61M +$1.63M +53,899 New
PPA
31
Parametric Portfolio Associates
Washington
$1.54M +$1.22M +40,529 +365%
Bank of New York Mellon
32
Bank of New York Mellon
New York
$1.42M +$645K +21,383 +82%
Victory Capital Management
33
Victory Capital Management
Texas
$1.34M +$1.3M +42,982 +2,149%
UCFA
34
United Capital Financial Advisors
Texas
$1.29M +$1.31M +43,320 New
GIM
35
Granahan Investment Management
Massachusetts
$1.21M -$366K -12,133 -23%
Ameriprise
36
Ameriprise
Minnesota
$1.13M +$1.15M +38,000 New
PCM
37
Perkins Capital Management
Minnesota
$1.01M +$195K +6,455 +24%
Renaissance Technologies
38
Renaissance Technologies
New York
$990K +$1M +33,200 New
BIM
39
Bogle Investment Management
Massachusetts
$882K +$70.7K +2,343 +9%
Allianz Asset Management
40
Allianz Asset Management
Germany
$874K +$885K +29,319 New
Point72 Asset Management
41
Point72 Asset Management
Connecticut
$822K +$832K +27,560 New
S
42
SignatureFD
Georgia
$779K +$302K +10,000 +62%
3C
43
361 Capital
Colorado
$733K +$742K +24,581 New
Squarepoint
44
Squarepoint
New York
$684K -$776K -25,729 -53%
Charles Schwab
45
Charles Schwab
California
$674K +$370K +12,267 +119%
RHJA
46
Rice Hall James & Associates
California
$673K +$681K +22,560 New
CIP
47
Chartwell Investment Partners
Pennsylvania
$630K +$71.7K +2,375 +13%
Los Angeles Capital Management
48
Los Angeles Capital Management
California
$621K +$628K +20,826 New
OFG
49
Oxford Financial Group
Indiana
$530K +$537K +17,796 New
SEI Investments
50
SEI Investments
Pennsylvania
$494K +$261K +8,657 +109%
1
2
3 4

CSTL Hedge Fund Activity: Q1 2020 in Review

89 of the 4,538 institutional investors tracked by Wall St. Rank reported a position in Castle Biosciences (CSTL) for Q1 2020, worth a combined $220M — up 25% from $176M a quarter earlier.

Buyers outnumbered sellers: 32 funds opened new CSTL positions and 10 closed out — a net gain of 22 holders — while 37 added to existing stakes and 14 trimmed.

The largest buyer was BlackRock, adding an estimated $8.45M. The largest seller was Portolan Capital Management, cutting an estimated $5.13M.

  • 89 institutional investors held Castle Biosciences (CSTL) as of Q1 2020, up from 67 in Q4 2019.
  • Funds reported $220M of Castle Biosciences stock for Q1 2020, up 25% quarter-over-quarter.
  • 32 funds opened new Castle Biosciences positions in Q1 2020 and 10 closed out, a net change of +22 holders.
  • The largest Castle Biosciences buyer in Q1 2020 was BlackRock, an estimated $8.45M added.
  • The largest Castle Biosciences seller in Q1 2020 was Portolan Capital Management, an estimated $5.13M sold.

Based on aggregated 13F filings for Q1 2020.